The distribution of j3-adrenergic receptors in sections of the human right and left coronary arteries and of the anterior intraventricular branch was studied by the use 
T he role of 3-adrenergic receptors in the control of large coronary vasomotion is debated (for a review see Reference 1) . In vitro studies demonstrated that activation of /8-adrenergic receptors results in coronary artery relaxation.2-4 However, it is not certain whether the same is true in vivo. In fact, the analysis of the effects of f3-adrenergic receptor stimulation on coronary resistance vessels is made difficult by the existence of a vasodilation secondary to the increase in myocardial metabolic demands elicited by ,B-adrenergic receptor agonists.2-4 Moreover, large epicardial coronary arteries are less sensitive to 8-adrenergic stimulation than the smaller epicardial vessels, suggesting that the responsiveness of the coronary arterial tree to 3-receptor agonists has an inverse relation with the size of coronary arteries. 5 Radioligand binding techniques associated with functional studies in the conscious animal demonstrated the existence of both ,81-and [32-adrenergic receptors in bovine large coronary arteries.6 Moreover, an equivalent vasodilation of large epicardial arteries after f31-or f32-adrenergic receptor stimulation was demonstrated, suggesting that both i31-and /32-receptor activation mediates vasodilation in the coronary vascular tree. [6] [7] [8] It was also suggested that in canine coronary arteries f3-adrenergic receptors may mediate endo- One-centimeter right and left coronary arteries and anterior interventricular branch samples were obtained from three subjects who died from car accidents (one female, 13 years old; two males, 17 and 19 years old). The hearts were removed to be transplanted, but when they arrived at the transplantation unit, they were found to be unsuitable for transplantation and were refused, becoming available for the present study. At an internal inspection, indeed, a traumatic tear of the atrial septum (in one specimen) and wide subendocardial hemorrhages in the left ventricle (in the other two cases) were noticed. Italian law does not allow hearts to be removed from donors for any reason but for transplantation, and that accounts for the inevitably small size of the sample available for the present study.
Since the removed specimens were intended to be used for transplantation, they were processed according to the routine protocol. First of all, the inferior vena cava was tied, and the right superior pulmonary vein was cut. The heart was emptied and consequently arrested. The aorta was immediately clamped, and the coronary arteries were perfused with a cold (4°C) hyperkalemic cardioplegic solution.
In the meantime, a cold Ringer's lactate solution was poured into the pericardial sac.
Soon afterward, the heart was removed, put on sterile ice prepared for transplantation, and introduced in a bag containing a cold (4°C) Ringer's solution. Such a bag was then introduced into two subsequent bags containing cold Ringer's fluid. These concentric bags were needed to preserve both low temperature and sterility in the inner bag, which was to be opened in the operating theater only. In a series of preliminary experiments, the optimal incubation and washing conditions were assessed (data not shown). The density of silver grains developed within the adventitia, media, and intima of the three epicardial arteries examined was assessed on dark-field-observed sections exposed for 3 days to the nuclear emulsion by counting the number of silver grains developed in
[PlI]CYP autoradiographs, according to the procedure described in an earlier study. 21 The silver grains were counted with a Zeiss II dark-field photomicroscope using a planapochromat x 40/1.0 objective and a 2-optovar to obtain a final magnification of x400. Counts were made independently by three investigators in 10 consecutive sections of each artery per subject (n=3); the sections were incubated with 70 pM (Figure 3) . From the analysis of these curves, it was established that the optimal concentrations of CGP 20712A and of ICI 118,551 to block PI,-and 032-adrenergic receptor binding sites were 100 and 70 nM, respectively. The same concentrations were reported by other authors11'13 to be optimal in human cardiac tissues and canine coronary arteries.
The proportion of ,i3-and 132-adrenergic receptor binding sites in slide-mounted sections of human coronary arteries examined is shown in and left coronary arteries and the anterior interventricular branch (Figures 4-6 (Figures 4-6 ).
Sections incubated with 70 pM [1251]CYP (a concentration two times higher than Ki value), in the presence of 100 nM CGP 20712A to label 1,2-adrenergic receptors, developed silver grains in the three arterial layers but with a higher density in the adventitia, the adventitial-medial border, and the intimal layer (Figure 6 ). Sections incubated with 70 pM [1251]CYP, in the presence of 70 nM ICI 118,551 to label /31-adrenergic receptors, developed silver grains primarily in the medial layer of human coronary arteries, most likely within smooth muscle (Figures 4 and 5) . PrlAdrenergic receptor binding sites were homogeneously distributed within the entire medial layer of different coronary arteries.
Analysis of the density of silver grains developed after autoradiography is summarized in Figure 7 . As can be seen, in agreement with receptor binding data, the highest accumulation of silver grains occurred in the right coronary artery, followed, in descending order, by the left coronary and the anterior communicating artery. The highest accumulation of 82-adrenergic receptors was noticeable in the adventitia of the anterior communicating artery followed by the left and then the right coronary arteries. The density of intimal silver grains is not significantly different in the three arteries examined (Figure 7 ). Discussion It has been suggested that both circulating and neurally released norepinephrine causes vasodilation of the large coronary arteries by interacting with ,/-adrenergic receptors.24 However, although no conclusive hypothesis can be drawn as to the significance of l3-adrenergic receptors in the physiological control of coronary hemodynamics, available evidence suggests an important role for ,B-adrenergic receptors in the control of coronary resistance vessels.
The main data on the pharmacological characterization of large coronary artery ,B-adrenergic receptors were obtained in bovine large coronary arteries by the use of binding techniques and functional studies in conscious animals.7 As outlined in the introductory section, both nonspecific (isoproterenol) or specific (such as prenarterol, a /3I-agonist, or pirbuterol, a /32-agonist) /3-adrenergic receptor agonists mediated vasodilation.7 This kind of f3-or :32-receptor mediated coronary vasodilation was considered independent of changes in cardiac metabolism and therefore linked to the activation of specific 3-adrenergic receptors in large epicardial arteries. Radioligand experiments demonstrated the existence of both subtypes of /3-adrenoceptors in the ratio 1.5:1.7 The first studies on the autoradiographic localization of 3-adrenergic receptors in the heart and coronary vasculature were published by Muntz and colleagues2526 in 1984 Muntz and colleagues2526 in and 1986 . Their work demonstrated, in the dog, a greater density of /3-ad- renergic receptors in intramyocardial coronary resistance vessels compared with large epicardial coronary arteries. This work was completed and expanded by a more recent binding and autoradiographic study'1 on the canine left anterior descending coronary artery; this study demonstrated the coexistence of PI,-and /32-adrenergic receptors in the proportion 85% :15%. 3,-Adrenergic receptors were found in the smooth muscle of the artery; /32-adrenergic receptors were located primarily on small nervous trunks of the perivascular connective tissue and on the adventitia. A medial localization of a few f32-adrenergic receptors was also noticeable.
Only sparse information is now available concerning the fB-adrenergic receptor subtypes in human coronary arteries (see Reference 13). This is due to the impossibility, in the past, of obtaining fresh samples of human epicardial arteries for biochemical or functional studies. In that respect, the increasing number of heart transplants in many countries allowed researchers to obtain more human material for their studies. However, when hearts are obtained from patients needing heart transplantation, there is the risk that pharmacological treatments or pathological processes may determine significant modifications of parameters to be evaluated. In our study, we had the opportunity to examine the main epicardial arteries from three healthy patients whose hearts were removed for transplantation. However, just after removal, these hearts were considered to be 
